Entelexo Biotherapeutics

Entelexo Biotherapeutics

制药业

Irvine，CA 31 位关注者

Entelexo has created a novel platform technology for engineering exosomes as a new approach to treating diseases.

关注

关于我们

Entelexo offers a new approach to treating diseases by focusing on the patients, analyzing patterns, and utilizing data to optimize product efficacy. Our engineered exosomes communicate with multiple, specific types of diseased cells simultaneously. This represents a logical step forward in treatment strategy, where for the first time the scope of novel treatments are capable of matching the natural complexities of diseases. Our rational engineering platform enables us to rapidly create and fine tune indication-specific exosome treatments.

网站
www.entelexo.com
所属行业
制药业
规模
2-10 人
总部
Irvine，CA
类型
私人持股
创立
2020
领域
Drug Development、Research & Development、Cellular Engineering、Exosome Engineering、Biotechnology、Pharmaceuticals、Therapeutics、Genetic Engineering、Protein Engineering和Disease Pathology

地点

相似主页